Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirschbaum, C.
Right arrow Articles by Hellhammer, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirschbaum, C.
Right arrow Articles by Hellhammer, D. H.
Related Collections
Right arrow Endocrinology
Right arrow Sexual Medicine: Female
Psychosomatic Medicine 61:154-162 (1999)
© 1999 American Psychosomatic Society


ORIGINAL ARTICLES

Impact of Gender, Menstrual Cycle Phase, and Oral Contraceptives on the Activity of the Hypothalamus-Pituitary-Adrenal Axis

Clemens Kirschbaum, PhD, Brigitte M. Kudielka, MS, Jens Gaab, MS, Nicole C. Schommer, MS and Dirk H. Hellhammer, PhD

From the Center for Psychobiological and Psychosomatic Research, University of Trier, Germany.

Address reprint requests to: Clemens Kirschbaum, PhD, Center for Psychobiological and Psychosomatic Research, University of Trier, Dietrichstr. 10–11, 54290 Trier, Germany. E-mail: Kirschba{at}uni-trier.de


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
OBJECTIVE: Results from animal and human studies suggest that disregulations of the hypothalamus-pituitary-adrenal (HPA) axis are involved in several behavioral, circulatory, endocrine, and immune disorders with clear-cut gender differences in disease prevalence. The aim of the present study was to investigate sex-specific HPA response patterns with a focus on the contribution of gonadal steroids as possible mediators.

METHODS: A total of 81 healthy adults were investigated in the present study. Twenty men, 19 women in the follicular phase of the menstrual cycle, 21 women in the luteal phase, and 21 women using oral contraceptives (OC) were exposed to a brief psychosocial stress test (Trier Social Stress Test; TSST) and injected with 0.25 mg ACTH1–24 on consecutive days. Basal HPA activity was investigated by repeatedly measuring cortisol levels immediately after awakening, as well as in 30-minute intervals from 9:00 AM to 9:00 PM. Additionally, questionnaires were used to assess psychological state and trait parameters.

RESULTS: Results show that the TSST induced significant increases in ACTH, salivary-free cortisol, total plasma cortisol, and heart rates, as well as increased wakefulness and reduced calmness in the total group. Significant group differences emerged for ACTH and salivary-free cortisol stress responses: Although men showed higher ACTH responses to the TSST compared with each of the three groups of women, salivary cortisol responses showed the following response pattern: Luteal = Men > Follicular = OC. The salivary cortisol responses to ACTH1–24 showed a similar response pattern: Luteal > Men > Follicular > OC. In contrast, total blood cortisol levels did not reveal any group difference between sexes or follicular versus luteal phase in either test. Although a similar salivary-free cortisol increase after awakening was found in the four groups, the circadian cortisol profile was significantly different throughout the first 4 hours of sampling. Questionnaire-derived psychological variables, as measured in the present study, could not explain the observed results.

CONCLUSIONS: We conclude that gender, menstrual cycle phase, and OC use exert important effects on HPA responsiveness to psychosocial stress in healthy subjects. Although men seem to have a stronger hypothalamic drive in response to stressful stimulation than women, differences in salivary-free cortisol levels, at least in part, may be explained by estradiol-induced changes in corticosteroid-binding protein levels. ACTH and cortisol secretion is not affected by OC use per se but the amount of bioavailable unbound cortisol ("free") is greatly reduced in this group of women after stimulation. Inasmuch as none of these differences between the study groups emerged in total blood cortisol levels, we strongly advocate for the simultaneous measurement of free and total cortisol levels in future studies on HPA functioning.

Key Words: psychosocial stress, • HPA axis, • sex differences, • menstrual cycle, • oral contraceptives, • salivary cortisol, • TSST, • CBG.

Abbreviations: ACTH = adrenocorticotropic hormone;; ANOVA = analysis of variance;; AUC = area under curve;; BDI = Beck Depression Inventory,; BMI = body mass index;; CBG = corticosteroid-binding globulin;; CRF = corticotropin-releasing hormone;; CNS = central nervous system;; DHEA = dehydroepiandrosterone;; FBL = Freiburger Beschwerde Liste;; HPA = hypothalamus-pituitary-adrenal axis;; MANOVA = multivariate analysis of variance; MDBF = Mehrdimensionaler Befindlichkeitsfragebogen;; OC = oral contraceptive;; RIA = radioimmunoassay;; TSST = Trier social stress test;; VAS = visual analog scale.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
A dysfunctional hypothalamus-pituitary-adrenal axis seems to be associated with manifestations of psychosomatic and psychiatric disorders. For example, HPA hyperactivity is often found in major depression (14) and also seems to be associated with susceptibility to infectious diseases (5) and cardiovascular problems (6). Hyporeactivity of the HPA system is associated with autoimmune processes, such as lupus erythematosus (7), multiple sclerosis (8), or neurodermatitis (9, 10). Significant gender differences in prevalence and incidence are well documented for these diseases (11).

Among the multitude of factors contributing to individual differences in HPA activity, a complex sexual dimorphism seems to exist. Evidence from animal as well as human studies suggests that there are marked differences in HPA response patterns between males and females. Whereas in rodents, basal ACTH and corticosterone levels, as well as responses to various stimuli, are uniformly greater in females (12, 13), the picture is more complex in humans. Men seem to secrete more ACTH than women with comparable total cortisol levels under basal conditions, which suggests an increased sensitivity of the female adrenal cortex (14). At the pituitary level, no gender differences are observed after injection of synthetic human corticotropin-releasing factor (h-CRF) with or without pretreatment with dexamethasone (1517). However, women may be more responsive to ovine CRF (18) or to a combination of h-CRF and vasopressin with respect to ACTH secretion (17). At a suprapituitary level, consistent gender differences in the HPA response to psychosocial stress have been observed in our laboratory. Concerning similar subjective or emotional responses, men always showed enhanced salivary (ie, unbound or "free") cortisol responses to a public speaking and mental arithmetic task in many studies (eg, 15, 19, 20). However, neither ACTH nor total blood cortisol levels have been measured in these studies, which would have allowed a more detailed localization of the observed sexual dimorphism.

Gonadal steroids, especially estradiol, seem to exert a substantial influence on the reactivity of the HPA axis responsiveness in rodents as well as in humans. Animal studies show that ovariectomy leads to attenuated HPA responses, whereas estradiol substitution induces HPA stimulation (2123). Similarly, a short-term estradiol treatment leads to an enhanced ACTH and cortisol stress response in healthy young men (24) and a 2-week treatment with DHEA, a sex steroid precursor, increases the ACTH stress response in elderly postmenopausal women (25).

Pronounced changes in estradiol levels occur over the course of the menstrual cycle with low levels in the early follicular phase, which peak shortly before or during ovulation and slowly decrease throughout the luteal phase. Studies investigating HPA functions with respect to the menstrual cycle found that basal as well as stimulated ACTH and corticosterone levels are highest around the time of ovulation in the rat (26, 27). In contrast, human studies have produced inconsistent results with respect to possible changes of HPA (re)activity over the menstrual cycle (2831).

Another consistent finding is rather puzzling and calls for explanation: women using ethinyl-estradiol-containing oral contraceptives (OC user) were found repeatedly to show blunted free cortisol responses to psychosocial or physical stress (3233). It is unknown whether the lower free cortisol responses reflect a hyporeactive HPA axis in these women. Alternatively, OC users may secrete similar amounts of cortisol, but due to the increased production of CBG induced by OC medication, the biologically active free cortisol fraction is largely reduced.

The aim of the present study, therefore, was to investigate pituitary and adrenal responses to a potent psychosocial laboratory stress protocol (the TSST) (34) in different phases of the menstrual cycle. These endocrine, heart rate, and subjective responses were compared with OC users and men, respectively. In addition, a Synacthen (ACTH1–24) test was performed to measure the capacity of the adrenal cortex in the experimental groups. Moreover, basal HPA activity was investigated with salivary-free cortisol levels after wakening in the morning and a 12-hour salivary-free cortisol profile.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Subjects
A total of 81 healthy men and women between 18 and 32 years of age participated in this study. The study sample was composed of 20 men, 19 women in the follicular phase (days 4–7) of the menstrual cycle, 21 women in the luteal phase (days 21–25), and 21 women who had used oral contraceptives (monophasic formulas, ethinyl-estradiol content: <50 µg) for at least 6 months. Menstrual cycle phase was validated post hoc endocrinologically by measurement of estradiol and progesterone levels. Because the available resources did not allow us to assess women repeatedly for assessment of ovulation, no midcycle group was included.

Before entering the study, all subjects provided written consent and underwent a comprehensive medical examination for past and current health problems. Smokers, subjects suffering from allergies, women with irregular menstrual cycles, or using multiphasic contraceptives were excluded. The study protocol was approved by the ethics committee of the University of Trier. Table 1 shows the number of subjects, mean age, BMI, sex steroid, and CBG levels for the four experimental groups.Go


View this table:
[in this window]
[in a new window]
 
Table 1. Sociodemographic Variables, Sex Steroid, and Corticosteroid-Binding Globulin Levels in the Four Experimental Groups
 

View this table:
[in this window]
[in a new window]
 
Table 2. Momentary Mood Assessed Before and After TSST With the Three Scales of the MDBF
 
Experimental Protocol
Each subject reported three times to the laboratory. The first appointment consisted of a medical examination and subjects received the material and detailed instructions for saliva collection at home (Salivette; Sarstedt, Rommelsdorf, Germany). On the second day, a Synacthen (ACTH1–24) (Ciba, Wehr, Germany) test was performed, followed by the psychosocial stress test on day 3. All experimental sessions started between 3:00 PM and 5:00 PM. A venous catheter was inserted and kept patent with a lock and subjects rested for 45 to 60 minutes. Thereafter, they filled in questionnaires (see below) before a baseline blood sample and a first saliva sample were collected. Then volunteers received an intravenous injection of 0.25 mg Synacthen on day 2 and additional blood and saliva samples were obtained 20, 30, 45, 60, and 90 minutes after injection. After baseline collection on day 3, subjects were exposed to the psychosocial stress test (TSST). The TSST, which mainly consists of a free speech and mental arithmetic task of 15 minutes duration performed in front of an audience, has been found repeatedly to induce endocrine and cardiovascular responses in 70% to 80% of all subjects tested (34). Because the endocrine responses to the TSST show a different pattern compared with the Synacthen test, blood and saliva samples were obtained 1, 10, 20, 30, 45, and 60 minutes after cessation of stress.

For assessment of basal free cortisol levels, participants collected saliva samples on the morning of day 2. Immediately after waking up and 15, 30, 45, and 60 minutes thereafter, saliva samples were obtained to measure the individual cortisol response to awakening. Recently, this laboratory has reported that salivary-free cortisol levels increase 50% to 150% within the first 30 minutes after waking up in the morning, independent of sleep duration, time of day, or other variables (35). Moreover, all subjects collected saliva from 9:00 AM to 9:00 PM at 30-minute intervals in their natural environment for assessment of the daytime circadian rhythm. The subjects were free to choose a day for collection of the circadian profile after completion of all laboratory tests. Accuracy of ambulatory saliva collection was not validated, but relied on the compliance of the subjects.

Psychological Assessment
Four psychological questionnaires were used to measure depression, physical complaints, mood changes, and perceived stressfulness of the TSST:

1. To control for a possible impact of depression on the HPA response (36), the Beck Depression Inventory (37) was used. Scores higher than 18 are assumed to represent clinically relevant depressive symptoms.
2. The short version of the Freiburger Beschwerdeliste (FBL) (38) measures physical complaints on five different scales (cardiac and blood pressure problems, gastrointestinal problems, tension, pain, total scale) with a total of 32 items. Subjects must choose one of six answers ranging from "not existent" to "very strong."
3. Momentary mood was assessed before and after the TSST with the MDBF, a German mood scale (39). This multidimensional questionnaire measures "elevated vs. depressed mood," "wakefulness vs. sleepiness," and "calmness vs. restlessness" on a five-point rating scale ranging from 1 = not at all to 5 = very much.
4. Six VAS were used for participants’ ratings of the stressfulness of the TSST. After cessation of the stress task, subjects were required to rate the extent of their personal involvement, how stressful, new, uncontrollable, and unpredictable the task was, and whether they anticipated negative consequences.

The Depression Inventory and the FBL were administered at baseline, mood was assessed before and after the stress task, and the VAS was applied only after the stress test.

Biochemical Analyses
Basal blood samples were used to measure estradiol (RIA; Biermann, Bad Nauheim, Germany), progesterone (RIA; IBL, Hamburg, Germany), and CBG (IBL, Hamburg, Germany). Salivary-free cortisol concentration in saliva was measured using a time-resolved immunoassay with fluorometric detection, as described in detail elsewhere (40). Total plasma cortisol was measured with a radioimmunoassay (RIA; IBL, Hamburg, Germany). ACTH was determined with a two-site chemiluminescence assay (Nichols Institute, Bad Nauheim, Germany). Interassay and intraassay coefficients of variance were below 12% and 10%, respectively, for all analyses.

Heart Rate
Heart rates were measured continuously at 1-minute intervals with ECG precision using wireless transmission (Sport Tester Profi, Polar Instruments, Gross-Gerau, Germany). Heart rate responses were computed from 7 minutes before stress exposure to 9 minutes after cessation of stress.

Statistical Analyses
ANOVAs for repeated measures were computed to analyze endocrine and heart rate responses to the stressor. To control for different baseline levels, hormone samples obtained directly before the stress exposure were treated as covariates. All reported results were corrected by the Greenhouse-Geisser procedure where appropriate. Newman-Keuls post hoc tests were applied for significant effects. Correlations were computed by Pearson product-moment correlations. Psychological parameters were analyzed by ANOVAs. Furthermore, factor analyses (principal component, varimax oblique) and reliability analyses were used to create the scale "stressfulness" based on items of the VAS. For all analyses, the significance level was {alpha} = 5%. For multiple comparisons the nominal {alpha} level was adjusted by Bonferroni correction. All results shown are means ± SEM.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
No subject had to be excluded from statistical analyses due to depression. BDI scores ranged between 0 and 18 and there were no differences among the four groups. Eleven subjects were classified as slightly depressed. Additional analyses could not reveal any significant correlations between depression scores and endocrine parameters (expressed as area under the curve). The physical complaint questionnaire (FBL) revealed that all subjects reported only minor physical impairments. As shown in Table 1, estradiol, progesterone, and CBC levels differed significantly among the four groups (F values = 18.22, 11.69, and 30.96; all p values < .0001). Newman-Keuls post hoc tests revealed that women in the luteal phase of the menstrual cycle had the highest estradiol and progesterone concentration with no differences between women in the follicular phase and men. OC users had the lowest levels of sex steroid levels with concurrent high CBG levels.

The psychosocial stress protocol caused significant endocrine, cardiovascular, and psychological responses. In the total group, ACTH, salivary-free cortisol, and total plasma cortisol increased significantly with 60% to 100% changes from baseline values. ACTH concentrations peaked 1 minute after cessation of the TSST with continuously decreasing hormone concentrations thereafter (ACTH: F = 48.28; p < .0001). Cortisol levels were highest 10 minutes after cessation of stress (salivary-free cortisol: F = 32.90; p < .0001; total plasma cortisol: F = 47.78; p < .0001). Maximum heart rate responses were observed between 6 and 13 minutes of stress exposure (F = 29.0; p < .0001). Correlations between ACTH and cortisol stress responses (expressed as areas under the response curves) were significant with r = .57 for total plasma cortisol (p < .001) and r = .53 for salivary-free cortisol (p < .001). Total plasma cortisol and salivary-free cortisol showed a correlation of r = .62 (p < .001).

MANOVAs revealed significant response differences between groups for ACTH stress responses (F = 2.52: p = .05; Figure 1) and salivary-free cortisol (F = 2.96; p = .007). Newman-Keuls post hoc tests confirmed that men showed significantly larger ACTH responses than women in the follicular phase at 1 and 10 minutes after stress exposure (both p values < .004) and at 1, 10, and 20 minutes after stress than both OC users and women in the luteal phase (all p values < .01). Concerning cortisol responsiveness, men had significantly higher salivary-free cortisol reactions than women in the follicular phase (all p values < .03) 10, 20, and 30 minutes after cessation of stress, and higher than OC users 1, 10, 20 and 30 after stress (all p values < .025). No differences in saliva cortisol emerged between men and women in the luteal phase (all not significant). Furthermore, women in the luteal phase showed higher salivary-free cortisol responses compared with women in the follicular phase 10 minutes after cessation of stress (p = .016) and higher saliva free cortisol concentrations than OC users 10 and 20 minutes after stress (both p values < .002). Women in the follicular phase and OC users did not differ in their salivary-free cortisol responses. Concerning total plasma cortisol, we only found significantly increased hormone concentrations 1 minute before stress in OC users compared with the other groups (F = 5.38; p < .002). No differences between groups emerged in total cortisol response patterns (F < 1). Likewise, heart rate responses did not differ among groups (F < 1).



View larger version (31K):
[in this window]
[in a new window]
 
Fig. 1. A, ACTH level; B, salivary-free cortisol level; C, total plasma cortisol level; and D, heart rate responses before and after psychosocial stress (TSST) in men, women in the luteal or follicular phase of the menstrual cycle, and oral contraceptive users. Values are mean ± SEM.

 
Exogenous stimulation with ACTH1–24 caused significant cortisol responses in the total group (total plasma cortisol: F = 30.96; p < .0001; salivary-free cortisol: F = 250.33; p < .0001; Figure 2). After ACTH1–24 challenge, both total plasma cortisol and salivary-free cortisol showed continuously increasing hormone concentrations in the observed time period. Concerning total plasma cortisol, MANOVAs did not reveal significant group differences (F = 1.66; p > .13). In contrast, salivary-free cortisol responses showed significant differences among the four groups of subjects (F = 2.28; p < .028). Women in the luteal phase of the menstrual cycle had the highest salivary-free cortisol responses followed by men, follicular phase women, and OC users, respectively. Post hoc tests revealed significantly higher reactions in the luteal phase compared with men 60 and 90 minutes after Synacthen injection (both p values < .01), compared with women in the follicular phase 30, 60, and 90 minutes after ACTH1–24 injection (all p values < .004), and compared with OC users 30, 45, 60, and 90 minutes after injection (all p values < .0001). Men showed higher levels than OC users 15, 30, 45, 60, and 90 minutes after injection (all p values < .05) with a similar response pattern as women in the follicular phase. The latter group showed higher salivary-free cortisol levels than OC users 30, 45, and 90 minutes after ACTH1–24 challenge.



View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2. A, salivary-free and B, total plasma cortisol responses to an injection of 0.25 mg ACTH1–24.

 
Salivary-free cortisol responses after stimulation with exogenous ACTH (expressed as AUC) correlated significantly with CBG levels (r = -.44; p < .0001), whereas after TSST-stimulation salivary-free cortisol levels (AUC) tended to correlate with CBG concentrations (r = -.21; p = .084; 2-tailed tests).

Analyses of the multidimensional mood scale, MDBF, revealed that stress exposure did not generally worsen mood (F = 1.99; p < .16), but significantly increased wakefulness (F = 8.35; p < .005) and reduced calmness (F = 8.83; p < .004) in the total group. No group differences in any of the three scales were observed.

The participants’ ratings of the stressfulness of the TSST were measured by six VASs. A factor analysis clustered the items to the factor "perceived stressfulness." Reliability of the resulting factor was {alpha} = .65 (Cronbach’s {alpha}). No differences emerged among groups, neither by comparing the clustered factor nor by comparing the single items. Also no group differences were found in any of the five scales of the questionnaire on physical complaints (FBL). Comparing sexes, women in general reported more strain than men (scale 3: F = 6.73; p < .011). However, after adjustment of nominal {alpha} level by Bonferroni correction for multiple comparisons, this result could be considered as a trend only.

Referring to basal HPA activity in their natural environment, the four groups did not show a clear-cut difference in salivary-free cortisol profiles after awakening (F = 1.33; p > .22). There was only a trend toward higher morning cortisol levels in women in the luteal phase (F = 2.70; p < .07) when the area under the response curve was compared. In 12-hour salivary-free cortisol profiles, ANOVA results indicated a small but statistically significant difference (F = 1.61; p > .044). However, the cortisol levels showed a rather inconclusive picture (Figure 3).



View larger version (29K):
[in this window]
[in a new window]
 
Fig. 3. Circadian saliva-free cortisol profiles obtained at 30-minute intervals between 9:00 AM and 9:00 PM. For better comparison, the insert shows the mean cortisol levels for two intervals with the largest differences among the four groups of subjects studied: 9:00 to 11:00 AM and 11:00 AM to 12:30 PM).

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
On the basis of findings from animal and human studies showing a significant impact of gonadal steroids on the activity of the HPA axis, the present study set out to investigate HPA responses to a potent laboratory stress test in subjects differing in endogenous gonadal steroid levels. Women in the follicular or luteal phase of their menstrual cycle were compared with women using estrogen-containing contraceptive pills (OC). Inasmuch as previous studies conducted in this laboratory have consistently found a clear-cut gender difference in the salivary-free cortisol response to psychosocial stress (15), an age and BMI-matched group of healthy men was also included. Inasmuch as possible group differences could have emerged because of alterations in adrenal cortex capacity or sensitivity, a Synacthen test was performed as a second challenge to the axis.

The results demonstrate that, whereas gender differences or changes in HPA functioning over the course of the menstrual cycle are barely reflected in basal parameters, they are rather prominent when the system is activated by a potent psychosocial stressor. Although two studies reported cyclic variations of basal ACTH levels throughout the menstrual cycle (41, 42), no differences in prestress ACTH concentrations were observed in the present study. This difference can be explained by the timing of blood sampling: Whereas in the previous studies samples were obtained early in the morning or values collapsed over a 12-hour period (41, 42), we measured baseline ACTH levels in the late afternoon hours only. Like ACTH, basal cortisol levels before stimulation or immediately after awakening in the morning did not seem to show cyclic variation as measured in the follicular versus luteal phase, this observation agrees with several previous reports (4244). There are only small, if any, differences in the circadian rhythm (9:00 AM-11:00 AM) between these subgroups.

In contrast to the findings of basal HPA activity, exposure to psychosocial stress resulted in different endocrine response profiles: Men showed larger ACTH increases compared with all three groups of women, lending support to the idea of an enhanced hypothalamic drive in men (45). It seems rather unlikely that differences in pituitary sensitivity to CRF are responsible for this result, inasmuch as challenge tests with human CRF result in similar ACTH responses in men and women in the same age group (16, 17).

Interestingly, the stress-induced cortisol patterns deviated to some degree from the ACTH picture: Men and women in the luteal phase had the largest salivary-free cortisol responses, which were clearly enhanced compared with women in the follicular phase. This was actually the first time that we have observed similar salivary-free cortisol responses to psychosocial stress in men and (one group of) women. In contrast to the biologically active free hormone fraction, total blood cortisol levels masked these differences with similar levels in the three groups (for discussion of the OC results, see below). This supports findings that suggest that the female adrenal cortex may be more sensitive to ACTH (45, 46) with no apparent change of net cortisol secretion in follicular versus luteal phases. The capacity of the female adrenal cortex to synthesize and secrete cortisol in response to maximal stimulation, however, is similar to men, as shown in the Synacthen test. However, women in the luteal phase clearly have higher circulating salivary-free cortisol levels after ACTH1–24 stimulation. These findings agree with a previous report (47).

The consistent differences between salivary-free and total plasma cortisol levels in response to psychosocial stress and synthetic ACTH1–24 in the present study may explain discrepant results on gender response differences described in the literature. The measurement of total cortisol levels only suggest that there is a similar cortisol response in the sense of cortisol secretion in men and women. However, this research strategy might miss a biologically important message: There seems to be a significant gender and menstrual cycle phase difference in the availability of free cortisol (ie, biologically active steroid). In our view, these results call for simultaneous measurement of free and total cortisol levels whenever feasible. Only this enables the investigator to relate hyporesponsive versus hyperresponsive patterns to differences in cortisol production or tissue availability of the endocrine signal. Whether the target tissue counterregulates intracellular signal cascades in response to a changing free glucocorticoid signal in vivo is completely unknown.

We have previously reported that women using oral contraceptives show blunted salivary-free cortisol responses to physical and psychosocial stress (32, 33) and suggested that this was due to the well-documented CBG-enhancing effect of ethinyl-estradiol (43, 48, 49). The present results strengthen this hypothesis: OC users can produce and secrete similar amounts of ACTH and total plasma cortisol in response to psychosocial stress and ACTH1–24; however, the salivary-free cortisol levels were clearly lower under both conditions. The notion that higher CBG levels may lead to lower salivary-free cortisol responses is supported by the negative correlations between cortisol and CBG. Although this might help to explain the group difference in saliva free cortisol levels, the observed gender difference in ACTH stress responsiveness without apparent influence of the menstrual cycle or OC use requires additional regulatory factors. Likely candidates are obviously gonadal steroids. Among them, estradiol is known to exert a strong stimulatory influence on the axis in several animal species (22, 23, 27, 5052) with important modulatory effects on mineralocorticoid and glucocorticoid receptors (26, 5356). Moreover, estradiol may directly enhance CRF gene transcription in the hypothalamus through binding to estrogen responsive elements on the CRF gene (57). But why should men have a stronger estrogen-driven CRF signal (as indicated by larger ACTH baselines and response levels), given that women usually produce significantly more estradiol over the course of the menstrual cycle than men? What seems to be a paradox may be explained by the metabolism of sex steroids in the brain. Most, but not all, CNS effects of testosterone are, in fact, estradiol-induced. In several tissues, it has been shown that testosterone must be aromatized to estradiol to modulate brain processes (5863). Thus, the relative abundance of free testosterone in men favors a stronger stimulation of hypothalamic or hippocampal structures after conversion into estradiol compared with women.

Although estradiol seems to be the best candidate for explaining the different HPA responses observed in this study, changes in progesterone levels also might have contributed to these findings. Data on the impact of progestins on the HPA axis in humans are sparse; however, the available results do not suggest a significant mediation of ACTH and cortisol stress responses (64, 65).

The present results raise a number of questions concerning the consequences of high/low HPA activity. Are subjects who vigorously respond to psychosocial stress in the laboratory more susceptible or more resilient with respect to health outcome measures? Are lower free cortisol levels in the follicular phase or in OC users prospectively associated with an increased number of physical complaints? Or does their organism adapt to this endocrine situation by increasing intracellular responses to a given cortisol signal by, eg, upregulation of receptors or transcription factors? Future psychobiological studies most probably will include the intracellular components of the HPA axis signal cascade in order to understand in more detail how this multilevel regulated endocrine system helps the individual to fight off diseases and remain healthy, despite ever-changing environmental strains and demands.


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
This study was supported by Grants 537/3–1 and Ki 537/6–1 (Heisenberg Programm) from the Deutsche Forschungsgemeinschaft.

Received for publication May 5, 1998.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 

  1. Gold PW, Chrousos GP, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 1984; 141: 619–27.[Abstract/Free Full Text]
  2. Sachar EJ, Hellman L, Fukushima DK, Gallagher TF. Cortisol production in depressive illness. A clinical and biochemical clarification. Arch Gen Psychiatry 1970; 23: 289–98.[Medline]
  3. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 1976; 33: 1039–44.[Abstract]
  4. Björntorp P. Behavior and metabolic disease. Int J Behav Med 1996; 3: 285–302.
  5. Mason D. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol Today 1991; 12: 57–60.[Medline]
  6. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171–9.[Free Full Text]
  7. Weiner H. Social and psychosocial factors in autoimmune disease.In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology. San Diego: Academic Press; 1991.p. 955–1011.
  8. Adams RD, Victor M. Multiple sclerosis and allied demyelinative diseases. Principles of neurology. New York: McGraw-Hill; 1989.p. 755–74.
  9. Buske-Kirschbaum A, Jobst S, Wustmans A, Kirschbaum C, Rauh W, Hellhammer D. Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom Med 1997; 59: 419–26.[Abstract/Free Full Text]
  10. Schnyder UW. Neurodermitis, asthma, rhinitis. Basel: Karger; 1960.
  11. McCarty DJ, Manzi S, Medsger TAJr, Ramsey-Goldman R, LaPorte RE, Kwoh CK. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 1995; 38: 1260–70.[Medline]
  12. Kitay JI. Pituitary-adrenal function in the rat after gonadectomy and gonadal hormone replacement. Endocrinology 1963; 73: 253–60.
  13. Kitay JI. Sex differences in adrenal cortical secretion in the rat. Endocrinology 1961; 68: 818–24.
  14. Roelfsema F, van den Berg G, Frölich M, Veldhuis JD, van Eijk A, Buurman MM, Etman BH. Sex-dependent alteration in cortisol response to endogeneous adrenocorticotropin. J Clin Endocrinol Metab 1993; 77: 234–40.[Abstract]
  15. Kirschbaum C, Wüst S, Hellhammer DH. Consistent sex differences in cortisol responses to psychological stress. Psychosom Med 1992; 54: 648–57.[Abstract/Free Full Text]
  16. Heuser IJ, Gotthardt U, Schweiger U, Schmider J, Lammers CH, Dettling M, Holsboer F. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol Aging 1994; 15: 227–31.[Medline]
  17. Born J, Ditschuneit I, Schreiber M, Dodt C, Fehm HL. Effects of age and gender on pituitary-adrenocortical responsiveness in humans. Eur J Endocrinol 1995; 132: 705–11.[Abstract]
  18. Gallucci WT, Baum A, Laue L, Rabin DS, Chrousos GP, Gold PW, Kling MA. Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. Health Psychol 1993; 12: 420–5.[Medline]
  19. Kirschbaum C, Klauer T, Filipp SH, Hellhammer DH: Sex-specific effects of social support on cortisol and subjective responses to acute psychological stress. Psychosom Med 1995; 57: 23–31.[Abstract/Free Full Text]
  20. Kirschbaum C, Pruessner J, Stone AA, Federenko I, Gaab J, Lintz D, Schommer N, Hellhammer DH. Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom Med 1995; 57: 468–74.[Abstract/Free Full Text]
  21. Critchlow V, Liebelt RA, Bar-Sela M, Mountcastle W, Lipscomb HS. Sex differences in resting pituitary-adrenal function in the rat. Am J Physiol 1963; 205: 807–15.
  22. Lesniewska B, Miskowiak B, Nowak M, Malendowicz LK. Sex differences in adrenocortical structure and function. XXVII. The effect of ether stress on ACTH and corticosterone in intact, gonadectomized, and testosterone- or estradiol-replaced rats. Res Exp Med (Berl) 1990; 190: 95–103.[Medline]
  23. Norman RL, Smith CJ, Pappas JD, Hall J. Exposure to ovarian steroids elicits a female pattern of cortisol levels in castrated male macaques. Steroids 1992; 57: 37–43.[Medline]
  24. Kirschbaum C, Schommer N, Federenko I, Gaab J, Neumann O, Oellers M, Rohleder N, Untiedt A, Hanker J, Pirke KM, Hellhammer DH. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men. J Clin Endocrinol Metab 1996; 81: 3639–43.[Abstract]
  25. Kudielka BM, Hellhammer J, Hellhammer DH, Wolf OT, Pirke K-M, Varadi E, Pilz J, Kirschbaum C. Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of a two-week DHEA treatment. J Clin Endocrinol Metab 1998; 83: 1756–61.[Abstract/Free Full Text]
  26. Carey MP, Deterd CH, de Koning J, Helmerhorst F, De Kloet ER. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. J Endocrinol 1995; 144: 311–21.[Abstract]
  27. Viau V, Meaney MJ. Variations in the hypothalamus-pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology 1991; 129: 2503–11.[Abstract]
  28. Tersman Z, Collings A, Eneroth P. Cardiovascular responses to psychological and physiological stressors during the menstrual cycle. Psychosom Med 1991; 53: 185–97.[Abstract/Free Full Text]
  29. Pomerleau CS, Garcia AW, Pomerleau OF, Cameron OG. The effects of menstrual phase and nicotine abstinence on nicotine intake and on biochemical and subjective measures in women smokers: a preliminary report. Psychoneuroendocrinology 1992; 17: 627–38.[Medline]
  30. Marinari KT, Leshner AI, Doyle MP. Menstrual cycle status and adrenocortical reactivity to psychological stress. Psychoneuroendocrinology 1976; 1: 213–8.[Medline]
  31. Abplanalp JM, Livingston L, Rose RM, Sandwisch D. Cortisol and growth hormone responses to psychological stress during the menstrual cycle. Psychosom Med 1977; 39: 158–77.[Abstract/Free Full Text]
  32. Kirschbaum C, Pirke K-M, Hellhammer DH. Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication. Psychoneuroendocrinology 1995; 20: 509–14.[Medline]
  33. Kirschbaum C, Platte P, Pirke K-M, Hellhammer DH. Adrenocortical activation following stressful exercise: further evidence for attenuated free cortisol responses in women using oral contraceptives. Stress Med 1996; 12: 137–43.
  34. Kirschbaum C, Pirke K-M, Hellhammer DH. The "Trier Social Stress Test"—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993; 28: 76–81.[Medline]
  35. Pruessner J, Wolf OT, Hellhammer DH, Buske-Kirschbaum A, von Auer K, Jobst S, et al. The cortisol response to awakening: consistency, reliability, and individual differences. Life Sci 1997; 61: 2539–49.[Medline]
  36. Gotthardt U, Schweiger U, Fahrenberg J, Lauer CJ, Holsboer F, Heuser I. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. Am J Physiol 1995; 268: R865–73.[Abstract/Free Full Text]
  37. Beck AT. Beck-Depressions-Inventar. Bern: Huber; 1979.
  38. Fahrenberg J. Die Freiburger Beschwerdeliste FBL. Diagnostica 1986; 20: 79–96.
  39. Steyer R, Schwenkmezger P, Notz P, Eid M. Testtheoretische Analysen des Mehrdimensionalen Befindlichkeitsfragebogens (MDBF). Diagnostica 1994; 40: 320–28.
  40. Dressendörfer RA, Kirschbaum C, Rohde W, Stahl F, Strasburger CJ. Synthesis of a cortisol-biotin conjugate and evaluation as tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 1992; 43: 683–92.[Medline]
  41. Genazzani AR, Lemarchand-Beraud T, Aubert ML, Felber JP. Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle. J Clin Endocrinol Metab 1975; 41: 431–7.[Abstract]
  42. Stewart PM, Penn R, Holder R, Parton A, Ratcliffe JG, London DR. The hypothalamo-pituitary-adrenal axis across the normal menstrual cycle and in polycystic ovary syndrome. Clin Endocrinol 1993; 38: 387–91.[Medline]
  43. Fujimoto NY, Villanueva AL, Hopper B, Moscinski M, Rebar RW. Increased adrenocortical responsiveness to exogenous ACTH in oral contraceptive users. Adv Contraception 1986; 2: 343–53.
  44. Kanaley JA, Boileau RA, Bahr JM, Misner JE, Nelson RA. Cortisol levels during prolonged exercise: the influence of menstrual phase and menstrual status. Int J Sports Med 1992; 13: 332–6.[Medline]
  45. Roelfsema F, van den Berg G, Frölich M, Veldhuis JD, Van Eijk A, Buurman MM, Etman BH. Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab 1993; 77: 234–40.
  46. Horrocks PM, Jones AF, Ratcliffe WA, Holder G, White A, Holder R, Ratcliffe JG, London DR. Patterns of ACTH and cortisol pulsatility over twenty-four hours in normal males and females. Clin Endocrinol 1990; 32: 127–34.[Medline]
  47. Kruyt N, Rolland R. Cortisol, 17{alpha}-OH-progesterone, and androgen response to a standardized ACTH-stimulation in different stages of the normal menstrual cycle. Acta Endocrinol 1982; 100: 427–33.
  48. Bulbrook RD, Herian M, Tong D, Hayward JL, Swain MC, Wang DY. Effect of steroidal contraceptives on levels of plasma androgen sulphates and cortisol. Lancet 1973; 1: 628–31.[Medline]
  49. Carr BR, Parker CRJ, Madden JD, MacDonald PC, Porter JC. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. J Clin Endocrinol Metab 1979; 49: 346–9.[Abstract]
  50. Bossmar T, Forsling M, Akerlund M. Circulating oxytocin and vasopressin is influenced by ovarian steroid replacement in women. Acta Obstet Gynecol Scand 1995; 74: 544–8.[Medline]
  51. Manin M, Delost P. Dynamic measure of production rate of cortisol in the mature Guinea pig in response to the stress of anesthesia: effect of estradiol. Steroids 1984; 43: 101–10.[Medline]
  52. Xiao E, Xia L, Shanen D, Khabele D, Ferin M. Stimulatory effects of interleukin-induced activation of the hypothalamo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol. Endocrinology 1994; 135: 2093–8.[Abstract]
  53. Burgess LH, Handa RJ. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 1992; 131: 1261–9.[Abstract]
  54. Pfeiffer A, Lapointe B, Barden N. Hormonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain. Endocrinology 1991; 129: 2166–74.[Abstract]
  55. Redei E, Li L, Halasz I, McGivern RF, Aird F. Fast glucocorticoid feedback inhibition of ACTH secretion in the ovariectomized rat: effect of chronic estrogen and progesterone. Neuroendocrinology 1994; 60: 113–23.[Medline]
  56. Turner BB. Sex differences in the binding of type I and type II corticosteroid receptors in rat hippocampus. Brain Res 1992; 29: 229–36.
  57. Vamvakopoulos NC, Chrousos GP. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J Clin Invest 1993; 92: 1896–902.
  58. Selmanoff MK, Brodkin LD, Weiner RI, Siiteri PK. Aromatization and 5alpha-reduction of androgens in discrete hypothalamic and limbic regions of the male and female rat. Endocrinology 1977; 101: 841–8.[Abstract]
  59. Weisz J, Gibbs C. Conversion of testosterone and androstenedione to estrogens in vitro by the brain of female rats. Endocrinology 1974; 94: 616–20.[Medline]
  60. Michael RP, Bonsall RW, Rees HD. Sites at which testosterone may act as an estrogen in the brain of the male primate. Neuroendocrinology 1987; 46: 511–21.[Medline]
  61. Flores F, Naftolin F, Ryan KJ. Aromatization of androstenedione and testosterone by rhesus monkey hypothalamus and limbic system. Neuroendocrinology 1973; 11: 177–82.[Medline]
  62. Naftolin F. Brain aromatization of androgens. J Reprod Med 1994; 39: 257–61.[Medline]
  63. Matera C, Wardlaw SL. Aromatization is not required for androgen-induced changes in proopiomelanocortin gene expression in the hypothalamus. Brain Res Mol Brain Res 1994; 27: 275–80.[Medline]
  64. Burleson MH, Malarkey WB, Cacioppo JT, Poehlman KM, Kiecolt-Glaser JK, Bernston GG, Glaser R. Postmenopausal hormone replacement: effects of autonomic, neuroendocrine, and immune reactivity to brief psychological stressors. Psychosom Med 1998; 60: 17–25.[Abstract/Free Full Text]
  65. Lindheim SR, Legro RS, Morris RS, Wong IL, Tran DQ, Vijod MA, Stanczyk FZ, Lobo RA. The effects of progestins on behavioral stress in postmenopausal women. J Soc Gynecol Invest 1994; 1: 79–83.[Medline]



This article has been cited by other articles:


Home page
J. Physiol.Home page
D. A. Slattery and I. D. Neumann
No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain
J. Physiol., January 15, 2008; 586(2): 377 - 385.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Barat, D. E. W. Livingstone, C. M. C. Elferink, C. R. McDonnell, B. R. Walker, and R. Andrew
Effects of Gonadectomy on Glucocorticoid Metabolism in Obese Zucker Rats
Endocrinology, October 1, 2007; 148(10): 4836 - 4843.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
T. F. Robles
Stress, Social Support, and Delayed Skin Barrier Recovery
Psychosom Med, October 1, 2007; 69(8): 807 - 815.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
B. K. Lee, T. A. Glass, M. J. McAtee, G. S. Wand, K. Bandeen-Roche, K. I. Bolla, and B. S. Schwartz
Associations of Salivary Cortisol With Cognitive Function in the Baltimore Memory Study
Arch Gen Psychiatry, July 1, 2007; 64(7): 810 - 818.
[Abstract] [Full Text] [PDF]


Home page
International Journal of Behavioral DevelopmentHome page
P. Pendry and E. K. Adam
Associations between parents' marital functioning, maternal parenting quality, maternal emotion and child cortisol levels
International Journal of Behavioral Development, May 1, 2007; 31(3): 218 - 231.
[Abstract] [PDF]


Home page
JSLHRHome page
J. Laures-Gore, C. M. Heim, and Y.-S. Hsu
Assessing Cortisol Reactivity to a Linguistic Task as a Marker of Stress in Individuals With Left-Hemisphere Stroke and Aphasia
J Speech Lang Hear Res, April 1, 2007; 50(2): 493 - 507.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Klose, M. Lange, A. K. Rasmussen, N. E. Skakkebaek, L. Hilsted, E. Haug, M. Andersen, and U. Feldt-Rasmussen
Factors Influencing the Adrenocorticotropin Test: Role of Contemporary Cortisol Assays, Body Composition, and Oral Contraceptive Agents
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1326 - 1333.
[Abstract] [Full Text] [PDF]


Home page
Adv. Physiol. Educ.Home page
M. F. Haussmann, C. M. Vleck, and E. S. Farrar
A laboratory exercise to illustrate increased salivary cortisol in response to three stressful conditions using competitive ELISA
Advan Physiol Educ, March 1, 2007; 31(1): 110 - 115.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Jones, A. Beda, A. M.V. Ward, C. Osmond, D. I.W. Phillips, V. M. Moore, and D. M. Simpson
Size at Birth and Autonomic Function During Psychological Stress
Hypertension, March 1, 2007; 49(3): 548 - 555.
[Abstract] [Full Text] [PDF]


Home page
Pers Soc Psychol BullHome page
C. Wrosch, G. E. Miller, M. F. Scheier, and S. B. de Pontet
Giving Up on Unattainable Goals: Benefits for Health?
Pers Soc Psychol Bull, February 1, 2007; 33(2): 251 - 265.
[Abstract] [PDF]


Home page
The Journal of Early AdolescenceHome page
V. L. Schiefelbein and E. J. Susman
Cortisol Levels and Longitudinal Cortisol Change as Predictors of Anxiety in Adolescents
The Journal of Early Adolescence, November 1, 2006; 26(4): 397 - 413.
[Abstract] [PDF]


Home page
Psychosom. Med.Home page
P. M. C. Mommersteeg, C. J. Heijnen, A. Kavelaars, and L. J. P. van Doornen
Immune and Endocrine Function in Burnout Syndrome
Psychosom Med, November 1, 2006; 68(6): 879 - 886.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. J. Sherman and L. LeResche
Does experimental pain response vary across the menstrual cycle? A methodological review
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R245 - R256.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
M. Zorawski, N. Q. Blanding, C. M. Kuhn, and K. S. LaBar
Effects of stress and sex on acquisition and consolidation of human fear conditioning
Learn. Mem., July 1, 2006; 13(4): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
D. Gallagher-Thompson, G. R. Shurgot, K. Rider, H. L. Gray, C. L. McKibbin, H. C. Kraemer, S. E. Sephton, and L. W. Thompson
Ethnicity, Stress, and Cortisol Function in Hispanic and Non-Hispanic White Women: A Preliminary Study of Family Dementia Caregivers and Noncaregivers
Am J Geriatr Psychiatry, April 1, 2006; 14(4): 334 - 342.
[Abstract] [Full Text] [PDF]


Home page
Journal of Social and Personal RelationshipsHome page
T. F. Robles, V. A. Shaffer, W. B. Malarkey, and J. K. Kiecolt-Glaser
Positive behaviors during marital conflict: Influences on stress hormones
Journal of Social and Personal Relationships, April 1, 2006; 23(2): 305 - 325.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Nierop, A. Bratsikas, A. Klinkenberg, U. M. Nater, R. Zimmermann, and U. Ehlert
Prolonged Salivary Cortisol Recovery in Second-Trimester Pregnant Women and Attenuated Salivary {alpha}-Amylase Responses to Psychosocial Stress in Human Pregnancy
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1329 - 1335.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. A. Nepomnaschy, K. B. Welch, D. S. McConnell, B. S. Low, B. I. Strassmann, and B. G. England
Cortisol levels and very early pregnancy loss in humans
PNAS, March 7, 2006; 103(10): 3938 - 3942.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. Ussher, R. West, P. Evans, A. Steptoe, A. McEwen, A. Clow, and F. Hucklebridge
Reduction in cortisol after smoking cessation among users of nicotine patches.
Psychosom Med, March 1, 2006; 68(2): 299 - 306.
[Abstract] [Full Text] [PDF]


Home page